Results 211 to 220 of about 131,258 (265)
Radiation therapy in a ductal carcinoma in situ patient with ornithine transcarbamylase deficiency: a case report. [PDF]
Radiat Oncol JKang I +10 more
europepmc +1 more source
Co-existence of fibroadenoma, intraductal carcinoma and invasive ductal carcinoma in the unilateral breast mass: a case report and literature review. [PDF]
Front OncolZhong S, Xu H, Ye X, Xu Y, Fan Z.
europepmc +1 more source
Prognostic significance and regulatory role of ACOT7 in the tumor immune microenvironment of breast invasive ductal carcinoma: a multi-omics analysis. [PDF]
Front ImmunolSong C +6 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Surgical Clinics of North America, 2018
Ductal carcinoma in situ has been stable in incidence for a decade and has an excellent prognosis. Breast conservation therapy is safe and effective for most patients. Adjuvant whole breast radiation therapy is recommended to reduce the risk of local recurrence.
FangMeng, Fu +2 more
openaire +2 more sources
Ductal carcinoma in situ has been stable in incidence for a decade and has an excellent prognosis. Breast conservation therapy is safe and effective for most patients. Adjuvant whole breast radiation therapy is recommended to reduce the risk of local recurrence.
FangMeng, Fu +2 more
openaire +2 more sources
Squamoid Eccrine Ductal Carcinoma
Cutis, 2021Squamoid eccrine ductal carcinoma (SEDC) is a rare and under-recognized primary cutaneous tumor with a high risk for local recurrence and metastasis. The tumor has a biphasic histologic appearance consisting of a superficial portion indistinguishable from squamous cell carcinoma (SCC) and a deeper component demonstrating eccrine ductal differentiation.
Steven A, Svoboda +5 more
openaire +2 more sources
Surgical Clinics of North America, 2003
DCIS is a heterogeneous disease whose natural history is poorly defined. Screening mammography has increased the detection rate of DCIS, but we remain unable to identify cases of DCIS that will not progress to invasive carcinoma during an individual's lifetime.
Faina, Nakhlis, Monica, Morrow
openaire +2 more sources
DCIS is a heterogeneous disease whose natural history is poorly defined. Screening mammography has increased the detection rate of DCIS, but we remain unable to identify cases of DCIS that will not progress to invasive carcinoma during an individual's lifetime.
Faina, Nakhlis, Monica, Morrow
openaire +2 more sources
Annals of Plastic Surgery, 2023
Abstract Salivary ductal carcinoma is an extremely rare tumor located in the parotid gland. This case details a salivary ductal carcinoma within the parotid gland of a 59-year-old man and its management.
Si-Qi, Mu, Xi, Zhang, Jie, Chen
openaire +2 more sources
Abstract Salivary ductal carcinoma is an extremely rare tumor located in the parotid gland. This case details a salivary ductal carcinoma within the parotid gland of a 59-year-old man and its management.
Si-Qi, Mu, Xi, Zhang, Jie, Chen
openaire +2 more sources
Surgical Clinics of North America, 2013
Management of ductal carcinoma in situ (DCIS) has evolved from radical surgery to the option of a more minimally invasive approach. Data show that breast conservation surgery performed with administration of radiotherapy, like mastectomy, is feasible and safe.
openaire +2 more sources
Management of ductal carcinoma in situ (DCIS) has evolved from radical surgery to the option of a more minimally invasive approach. Data show that breast conservation surgery performed with administration of radiotherapy, like mastectomy, is feasible and safe.
openaire +2 more sources